medigraphic.com
ISSN 0028-3851 (Print)

2023, Number 4

<< Back

Rev Neurol Neurocir Psiquiat 2023; 51 (4)

Prone ventilation in COVID-19 with severe acute respiratory distress syndrome and aneurysmal subarachnoid hemorrhage

Arroyo-Sánchez AS, Aguirre-Mejía RY

Language: Spanish
References: 11
Page: 196-201
PDF size: 363.01 Kb.


ABSTRACT

The clinical management of the association of severe acute respiratory distress syndrome due to COVID-19 in patients with untreated aneurysmal subarachnoid hemorrhage is challenging due to the lack of high-grade evidence and the risk of neurological complications that may be caused by ventilatory therapy. We present the clinical characteristics, management and results of a patient with this association of pathologies, during the height of the second wave of the COVID-19 pandemic, in a hospital in Peru.


REFERENCES

  1. Florez WA, García-Ballestas E, Deora H, Agrawal A, Martinez-Perez R, Galwankar S et al. Intracranial hypertension in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev. 2021; 44 (1): 203-211.

  2. Mazeraud A, Robba C, Rebora P, Iaquaniello C, Vargiolu A, Rass V et al. Acute distress respiratory syndrome after subarachnoid hemorrhage: incidence and impact on the outcome in a large multicenter, retrospective cohort. Neurocrit Care. 2021; 34 (3): 1000-1008.

  3. Towner JE, Rahmani R, Zammit CG, Khan IR, Paul DA, Bhalla T et al. Mechanical ventilation in aneurysmal subarachnoid hemorrhage: systematic review and recommendations. Crit Care. 2020; 24 (1): 575.

  4. Panther EJ, Lucke-Wold B. Subarachnoid hemorrhage: management considerations for COVID-19. Explor Neuroprotective Ther. 2022; 2 (2): 65-73.

  5. World Health Organization. COVID-19 clinical management. Living guidance 23 November 2021 [internet]. WHO; 2021 [Cited 2021 jun 13]. Available in: https://apps.who.int/iris/bitstream/handle/10665/338882/WHO-2019-nCoV-clinical-2021.1-eng.pdf?sequence=1&isAllowed=y

  6. Qureshi AI, Baskett WI, Huang W, Shyu D, Myers D, Lobanova I et al. Subarachnoid hemorrhage and COVID-19: an analysis of 282,718 patients. World Neurosurg. 2021; 151: e615-e620.

  7. Ravindra VM, Grandhi R, Delic A, Hohmann S, Shippey E, Tirschwell D et al. Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States. PLoS One. 2021; 16 (4): e0248728.

  8. Cornejo R, Romero C, Ugalde D, Bustos P, Diaz G, Galvez R et al. High-volume hemofiltration and prone ventilation in subarachnoid hemorrhage complicated by severe acute respiratory distress syndrome and refractory septic shock. Rev Bras Ter Intensiva. 2014; 26 (2): 193-199.

  9. Cezar-Junior AB, Faquini IV, Silva JL, de Carvalho Junior EV, Lemos LE et al. Subarachnoid hemorrhage and COVID-19: association or coincidence? Medicine. 2020; 99: 51.

  10. Dodd WS, Jabbour PM, Sweid A, Tjoumakaris S, Gooch MR, Al Saiegh F et al. Aneurysmal subarachnoid hemorrhage in patients with coronavirus disease 2019 (COVID-19): a case series. World Neurosurg. 2021; 153: e259-e264.

  11. Khan D, Naderi S, Ahmadi M, Ghorbani A, Cornelius JF, Hanggi D et al. Intracranial aneurysm rupture after SARS-CoV2 infection: case report and review of literature. Pathogens. 2022; 11 (6): 617.




2020     |     www.medigraphic.com